Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin vs Atorvastatin in UK Asian Subjects with Hypercholesterolaemia
NCT00427960Phase 4Terminated
- Sponsor
- AstraZeneca
- Start
- Dec 2006
- Primary completion
- Feb 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in hypercholesterolemia, sponsored by AstraZeneca. Started Dec 2006; status: terminated.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00427960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00427960.